Last week, we welcomed the US Ambassador to the UK, Warren Stephens, to The Discovery Centre, our global headquarters and state-of-the-art R&D facility in Cambridge.
@USAinUK
The visit was a fantastic opportunity to showcase the boundary-pushing science taking place at The DISC, our role in the Cambridge and UK life sciences ecosystem and our deep commitment to the United States.
By deepening the collaboration between the UK and the US, we are accelerating scientific discovery and engaging with governments to deliver the next generation of medicines for patients worldwide.
Honoured to be named Green Business of the Year at the British Business Awards ! 🏆 Through our Ambition Zero Carbon strategy, we've cut emissions by 88% from 205 baseline, transitioned to 18,000 EVs & launched the UK's first unsubsidised biomethane plant for life sciences.
We're in great company 🙌
Proud to be named #6 on LinkedIn's 2026 Top Companies List for the UK, recognition that speaks to the culture and career opportunities we've built together at AstraZeneca.
Last night we were honoured to receive two Bionow awards, which celebrate the Northern UK life sciences community. These wins reflect our dedication to innovation, skills and patient impact. Read on to learn more.
Huge congratulations to Holly Rimmer for winning the Bionow One to Watch Award. As a Genomics Apprentice, Holly delivers clinical trials at scale. She also champions AI adoption, inclusion and sustainability across our organisation.
We were also incredibly proud to receive the inaugural Bionow Enduring Contribution to UK Life Sciences Award for AstraZeneca Macclesfield. This award recognises our site's sustained excellence and long-term industrial leadership over six decades.
At a ceremony held at the London Stock Exchange, AstraZeneca has once again been recognised as Britain’s Most Admired Company in the Healthcare sector for 2025.
This recognition is a testament to our teams and their relentless pursuit of scientific progress. #BMAC2025
The latest episode of the #CancerProjectZero video series with @HSJnews is live! Join experts Professor Frank Chinegwundoh MBE and Oliver Kemp MBE exploring what equity in cancer care means and why it is so important.
🎥 Watch now: bit.ly/3LEeMgi
To celebrate International Day of the Girl, we welcomed young women into leadership roles at AstraZeneca as part of @Plan International UK's #GirlsTakeovers! These future leaders brought fresh perspectives to our boardrooms & labs.
Their insights inspired conversations about empowering young people in STEM. By creating opportunities like this, we're building a more equitable future for people, society and the planet. #GirlsBelongHere#YoungHealthProgramme
The second episode of our #CancerProjectZero series with @HSJnews is live! Jack Serle chats with AstraZeneca’s Sonny Shergill and Will Rickets @tb_doc, on how AI could help work towards eliminating cancer as a cause of death.
👉 Watch now: bit.ly/3WOEscs
On Saturday, we sponsored and attended Big Biology Day; a brilliant free day of educational fun at @HillsRoadNews in Cambridge.
19 UK STEM volunteers from across AstraZeneca engaged over 2000 attendees with creative activities throughout the day.
Activities included:
🥽Dress like a scientist
🗝️ Crack the code to manufacture a vaccine
🦠Make a model of a virus and antibody
🧪Complete a lab experiment
💡Learn more about career opportunities in STEM
Thank you to the organisers for another inspiring event and to our amazing volunteers who came together to bring science to life for the young minds in our community. #WhatScienceCanDo#BigBiologyDay#MedicineMakers
Every day, 17 people in the UK are diagnosed with liver cancer. There is a rising incidence in liver cancer in the UK that is being driven by conditions such as conditions such as cirrhosis, non-alcoholic fatty liver disease, and diabetes, which cause chronic liver inflammation.
Every day, 17 people in the UK are diagnosed with liver cancer. There is a rising incidence in liver cancer in the UK that is being driven by conditions such as conditions such as cirrhosis, non-alcoholic fatty liver disease, and diabetes, which cause chronic liver inflammation.